Achieves 14% Revenue Growth - Exceeding Expectations
Raises Full Year Guidance
Delivered record first quarter Revenue of $17.7 million
Reduced Net Loss by 35% and Net Cash Used in Operations by 52%
Successfully launched next generation device Butterfly iQ3™ and training app ScanLab™
Received European Union Medical Device Regulation (EU MDR) certification
6fe*****
アフターで+18% 0.93ドル
以下、決算見出し
Achieves 14% Revenue Growth - Exceeding Expectations
Raises Full Year Guidance
Delivered record first quarter Revenue of $17.7 million
Reduced Net Loss by 35% and Net Cash Used in Operations by 52%
Successfully launched next generation device Butterfly iQ3™ and training app ScanLab™
Received European Union Medical Device Regulation (EU MDR) certification